Agenda: Tuesday, April 30, 2019
Harvard Medical School
Keynote
Governor Charlie Baker
8:30 - 9:00 am
Panel: Colorescience, Recros Medica, ChannelMedsystems, Renovia Inc.
9:00 - 9:30 am
Panel: 28-7, Millendo, ArcherDX, Axial
9:30 - 10:00 am
Biotech Revolution
Phil Sharp, Co-Founder, Biogen/Alnylam; James Mullen, former CEO, Biogen
10:00 - 10:30 am
Biotech Innovation
Craig Wheeler, CEO, Momenta; Roger Tung, CEO, Concert Pharmaceuticals
10:30 - 11:00 am
The Long and Winding Road to Drug Approval
John Maraganore, CEO, Alnylam; Robert Forrester, CEO, Verastem; Francois Nader, Chair, Acceleron
11:00 - 11:30 am
Diseases of Aging
David Sinclair, Co-Founder, Sirtris; Chen Schor, CEO, resTORbio
11:30 am - 12:00 pm
Big Ideas, Powerful Syndicate
Steve Elledge, Harvard Medical School; Markus Goebel, Novartis Venture Fund; Steve Krauss, Bessemer Venture Fund; Krishna Yeshwant, Google Ventures; Leon Chen, 6 Dimensions
12:00 - 12:30 pm
Networking Lunch
12:30 - 1:30 pm
Fireside Chat
George Daley, Dean, Harvard Medical School; Betsy Nabel, President, Brigham & Women's
1:30 - 1:50 pm
Boston-Centric BioPharma
Bob Coughlin, MassBio; Martin Mackay, RallyBio; Rob Perez, Life Science Cares; Mark Stevenson, COO, Thermo Fisher Scientific
1:50 - 2:20 pm
Big Biotech and Pharma R&D
Al Sandrock, CMO, Biogen; Yong Jun Liu, Global Head, R&D, Sanofi
2:20 - 2:50 pm
Biotech Industry Trends
Peter Hutt, Former GC, FDA; Bill Heiden, CEO, AMAG
2:50 - 3:20 pm
Deal Making Forecast
Ivana Magovcevic Liebisch, EVP & CBO, Ipsen
3:20 - 3:50 pm
Networking Reception
3:50 - 4:30 pm